Skip to main content
. 2024 Oct 1;43:406–422. doi: 10.1016/j.bioactmat.2024.09.020

Fig. 9.

Fig. 9

The mechanism of Ber-lipo inhibiting the activation of TLR4/MyD88/NF-κB signaling pathway to restrain proinflammatory state. In brief, Ber-lipo inhibited TLR4 (LPS receptor) expression, then reduced the recruitment of MyD88, and further suppressed the IκBα activation, thereby hijacking NF-κB p65 nuclear translocation to mitigate inflammatory response.